TetraLogic Pharmaceuticals Corp Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. TetraLogic Pharmaceuticals current Real Value cannot be determined due to lack of data. The regular price of TetraLogic Pharmaceuticals is $0.0. Our model measures the value of TetraLogic Pharmaceuticals from inspecting the company fundamentals such as Price To Earning of (0.03) X, return on asset of -0.2, and Shares Owned By Institutions of 0.01 % as well as reviewing its technical indicators and probability of bankruptcy.
TetraLogic Pharmaceuticals Total Value Analysis
TetraLogic Pharmaceuticals Corp is at this time estimated to have valuation of 458.72 K with market capitalization of 229.36 K, debt of 28.33 M, and cash on hands of 5.89 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the TetraLogic Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
458.72 K | 229.36 K | 28.33 M | 5.89 M |
TetraLogic Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of TetraLogic is to check how much profit was generated for every dollar of assets it reports. TetraLogic Pharmaceuticals has a negative utilization of assets of -0.2 %, losing $0.001959 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of TetraLogic Pharmaceuticals Corp shows how discouraging it operates for each dollar spent on its assets.TetraLogic Pharmaceuticals Ownership Allocation
TetraLogic Pharmaceuticals shows a total of 24.47 Million outstanding shares. About 99.99 % of TetraLogic Pharmaceuticals outstanding shares are held by general public with 0.01 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.TetraLogic Pharmaceuticals Profitability Analysis
Net Loss for the year was (49.72 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates TetraLogic Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in TetraLogic Pharmaceuticals and how it compares across the competition.
TetraLogic Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as TetraLogic Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 23.7 M | |
| Retained Earnings | -175.6 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in TetraLogic Pink Sheet
If you are still planning to invest in TetraLogic Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TetraLogic Pharmaceuticals' history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |